EUVIMEDEUVIMED entdecken
Crossref

A pilot study of the immune microenvironment of GI neuroendocrine carcinoma

Andrew McDonald iD, Vaidehi Avadhani, Gabriela Oprea-Ilies, Katerina Zakka, Gregory B Lesinski, Olumide B Gbolahan, Olatunji Alese

Endocrine-Related Cancer · 2024

DOI: 10.1530/erc-24-0046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2024. Verfasst von Andrew McDonald und 6 weiteren Autor:innen. Beteiligte Einrichtung: Winship Cancer Institute at Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastroenteropancreatic high-grade (HG) neuroendocrine carcinoma (GEP-NEC) is an aggressive malignancy with limited treatment options and increasing incidence in the United States. Due to the rarity of the cancer and heterogeneity of the primary tumor location, data on GEP-NEC oncogenesis and its interaction with the host immune system are limited. A greater understanding of GEP-NEC and its tumor microenvironment (TME) would benefit efforts to develop more effective targeted therapies and rationally adapt immunotherapy to this disease. In this study, we profiled the expression of 770 unique genes using 21 biopsy samples from patients with GEP-NEC using the NanoString nCounter PanCancer IO 360 platform. Our results show several trends evident within the GEP-NEC TME. Greater expression of genes indicative of immune cell infiltration was present within the TME of patients 6 months OS had tumors with elevated NK cell gene signatures compared to patients with poor survival. Further, the analysis revealed numerous differentially expressed genes based on patient age, tumor location, response to treatment, and OS, which warrant future validation for assessing the relationship with clinical outcomes in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentCarcinoma, NeuroendocrineHumansPilot ProjectsMaleFemaleMiddle AgedAgedPancreatic NeoplasmsAdultGastrointestinal NeoplasmsIntestinal NeoplasmsStomach NeoplasmsNeuroendocrine Tumors

Stichwörter der Autor:innen

carcinomagastroenteropancreaticmicroenvironmentneuroendocrine

Autor:innen und Institutionen

  • Winship Cancer Institute at Emory University, Atlanta, Georgia, USA.
  • Grady Memorial Hospital, Atlanta, Georgia, USA.

ORCID-Profile: Andrew McDonald

Zitieren

APA

McDonald, A., Avadhani, V., Oprea-Ilies, G., Zakka, K., Lesinski, G. B., Gbolahan, O. B., & Alese, O. (2024). A pilot study of the immune microenvironment of GI neuroendocrine carcinoma. Endocrine-Related Cancer. https://doi.org/10.1530/erc-24-0046

Vancouver

McDonald A, Avadhani V, Oprea-Ilies G, Zakka K, Lesinski GB, Gbolahan OB, et al. A pilot study of the immune microenvironment of GI neuroendocrine carcinoma. Endocrine-Related Cancer. 2024. doi:10.1530/erc-24-0046

BibTeX
@article{McDonald2024,
  author = {McDonald, Andrew and Avadhani, Vaidehi and Oprea-Ilies, Gabriela and Zakka, Katerina and Lesinski, Gregory B and Gbolahan, Olumide B and Alese, Olatunji},
  title = {A pilot study of the immune microenvironment of GI neuroendocrine carcinoma},
  journal = {Endocrine-Related Cancer},
  year = {2024},
  doi = {10.1530/erc-24-0046}
}
Kostenlos starten →